Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 32-38

  Moreno Navarrete, José María ^a   Ortega, Francisco ^a   Sánchez Garrido, Miguel Ángel ^b   Sabater, Mònica ^a   Ricart, Wifredo ^a   Zorzano, Antonio ^c   Tena Sempere, Manuel ^b   Fernández Real, José Manuel ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adipose tissue; S6K1; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; RIBOSOME PROTEIN; ROSIGLITAZONE; S6 KINASE 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROADIPOCYTE; RAT; SUBCUTANEOUS FAT; WESTERN BLOTTING;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; OBESITY, MORBID; PHOSPHORYLATION; RATS; RATS, WISTAR; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RIBOSOMAL PROTEIN S6 KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; THIAZOLIDINEDIONES; THREONINE;

RATTUS;

EID: 84870452466     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.01.005     Document Type: Article

References (24)

1. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637.
2. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat Genet 2000, 26:13.
3. Um S.H., D'Alessio D., Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 2006, 3:393-402.
4. Khamzina L., Veilleux A., Bergeron S., Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005, 146:1473-1481.
5. Le Bacquer O., Petroulakis E., Paglialunga S., Poulin F., Richard D., Cianflone K., et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007, 117:387-396.
6. Zhang J., Gao Z., Yin J., Quon M.J., Ye J. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem 2008, 283:35375-35382.
7. Adochio R., Leitner J.W., Hedlund R., Draznin B. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase. Endocrinology 2009, 150:1165-1173.
8. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004, 431:200-205.
9. Pullen N., Thomas G. The modular phosphorylation and activation of p70s6k. FEBS Lett 1997, 410:78-82.
10. Weng Q.P., Kozlowski M., Belham C., Zhang A., Comb M.J., Avruch J. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J Biol Chem 1998, 273:16621-16629.
11. Nilsson C., Niklasson M., Eriksson E., Bjorntorp P., Holmang A. Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J Clin Invest 1998, 101:74-78.
12. Gao Z., Yin J., Zhang J., He Q., McGuinness O.P., Ye J. Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K. J Biol Chem 2009, 284:18368-18376.
13. Jiang X., Dallas-Yang Q., Biswas S., Li Z., Zhang B.B. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. Biochem J 2004, 377:339-346.
14. Jiang Y., Zhang B.B. Modulation of insulin signaling by insulin sensitizers. Biochem Soc Trans 2005, 33:358-361.
15. Ortega F.J., Moreno-Navarrete J.M., Ribas V., Esteve E., Rodriguez-Hermosa J.I., Ruiz B., et al. Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity (Silver Spring) 2009, 17:2134-2141.
16. Walker G.E., Marzullo P., Verti B., Guzzaloni G., Maestrini S., Zurleni F., et al. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects. Obesity (Silver Spring) 2008, 16:1983-1991.
17. MacLaren R., Cui W., Simard S., Cianflone K. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res 2008, 49:308-323.
18. Festuccia W.T., Blanchard P.G., Turcotte V., Laplante M., Sariahmetoglu M., Brindley D.N., et al. Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism. J Lipid Res 2009, 50:1185-1194.
19. Kim H.J., Jung T.W., Kang E.S., Kim D.J., Ahn C.W., Lee K.W., et al. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. Metabolism 2007, 56:676-685.
20. Ranganathan G., Unal R., Pokrovskaya I., Yao-Borengasser A., Phanavanh B., Lecka-Czernik B., et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 2006, 47:2444-2450.
21. Ortega F.J., Mayas D., Moreno-Navarrete J.M., Catalán V., Gómez-Ambrosi J., Esteve E., et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 2010, 18:13-20.
22. Barbour L.A., McCurdy C.E., Hernandez T.L., Friedman J.E. Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Metab 2011, 96:1431-1441.
23. Younis H.S., Hirakawa B., Scott W., Tran P., Bhat G., Affolter T., et al. Antisense inhibition of S6 kinase 1 produces improved glucose tolerance and is well tolerated for 4 weeks of treatment in rats. Pharmacology 2011, 87:11-23.
24. She P., Van Horn C., Reid T., Hutson S.M., Cooney R.N., Lynch C.J. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007, 293:E1552-E1563.